Screening
Screening for a known pathogenic mutation in an AIP family is most effective for detecting asymptomatic relatives. Measurement of erythrocyte porphobilinogen deaminase activity is less reliable than DNA methods but can be used if an index case has demonstrated AIP with a decreased enzyme activity. All relatives should be screened.[16] Screening of children is less urgent than in adults because clinical expression in children is very rare.
Use of this content is subject to our disclaimer